首页> 外文OA文献 >Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation.
【2h】

Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation.

机译:乳腺癌细胞在体外释放的细胞角蛋白8与纤溶酶原和组织型纤溶酶原激活剂结合,并促进纤溶酶原激活。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell-surface activation of plasminogen may be important in diseases that involve cellular migration, including atherosclerosis and tumour invasion/metastasis. Cytokeratin 8 (CK 8) has been identified as a plasminogen-binding protein expressed on the external surfaces of hepatocytes and breast carcinoma cells [Hembrough, Vasudevan, Allietta, Glass and Gonias (1995) J. Cell Sci. 108, 1071-1082]. In this investigation, we demonstrate that a soluble form of CK 8 is released into the culture medium of breast cancer cell lines. The released CK 8 is in the form of variably sized polymers that bind plasminogen and promote the activation of [Glu1]plasminogen and [Lys78]plasminogen by single-chain tissue-type plasminogen activator (sct-PA). To assess the mechanism by which CK 8 promotes plasminogen activation, CK 8 was purified from rat hepatocytes and immobilized in microtitre plates. Immobilized CK 8 bound 125I-plasminogen and 125I-sct-PA in a specific and saturable manner. The KDs were 160 +/- 40 nM and 250 +/- 48 nM, respectively. Activation of plasminogen bound to immobilized CK 8 was accelerated compared with plasminogen in solution, as determined using a coupled-substrate fluorescence assay and SDS/PAGE. The ability of CK 8 to promote plasminogen activation may be important in the pericellular spaces surrounding breast cancer cells and at the cell surface.
机译:纤溶酶原的细胞表面活化在涉及细胞迁移的疾病中可能很重要,包括动脉粥样硬化和肿瘤浸润/转移。细胞角蛋白8(CK 8)已被鉴定为在肝细胞和乳腺癌细胞的外表面表达的纤溶酶原结合蛋白[Hembrough,Vasudevan,Allietta,Glass and Gonias(1995)J.Cell Sci.Natl.Acad.Sci.USA 90:5873-5877。 108,1071-1082]。在这项研究中,我们证明了可溶性形式的CK 8被释放到乳腺癌细胞系的培养基中。释放的CK 8呈大小可变的聚合物形式,该聚合物结合纤溶酶原并通过单链组织型纤溶酶原激活剂(sct-PA)促进[Glu1]纤溶酶原和[Lys78]纤溶酶原的活化。为了评估CK 8促进纤溶酶原激活的机制,从大鼠肝细胞中纯化了CK 8并将其固定在微量滴定板中。固定的CK 8以特定且可饱和的方式结合125I-纤溶酶原和125I-sct-PA。 KD分别为160 +/- 40 nM和250 +/- 48 nM。与溶液中的纤溶酶原相比,与溶液中的纤溶酶原相比,与固定化CK 8结合的纤溶酶原的活化得以加速,这是通过偶联底物荧光测定法和SDS / PAGE确定的。 CK 8促进纤溶酶原激活的能力在乳腺癌细胞周围的细胞周围空间和细胞表面中可能很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号